2009
DOI: 10.1056/nejmoa0804626
|View full text |Cite|
|
Sign up to set email alerts
|

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

75
2,393
15
168

Year Published

2010
2010
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 3,814 publications
(2,754 citation statements)
references
References 38 publications
75
2,393
15
168
Order By: Relevance
“…However, this extraordinary reduction should be viewed in wider perspective; indeed, although not directly the objective of the current investigation, “no‐touch” OPCAB might offer the long‐term survival benefit of CABG over PCI,2, 35 together with similar or lower than PCI 30‐day stroke rates 36, 37. The discussion about potential shortcomings of CABG as compared to PCI was fueled after the first large industry‐funded trial3 found significantly higher rates of major adverse cardiac and cerebrovascular events in the PCI group (17.8% versus 12.4% for CABG; P =0.002), in large part because of an increased rate of repeat revascularization (13.5% versus 5.9%); however, at 12 months, strokes were 4‐fold more likely to occur with CABG (2.2% versus 0.6% with PCI; P =0.003). None of the following studies comparing PCI with OPCAB38, 39, 40, 41 were powered for stroke, and none reports the extent of “no‐touch” technique in the CABG group.…”
Section: Discussionmentioning
confidence: 94%
“…However, this extraordinary reduction should be viewed in wider perspective; indeed, although not directly the objective of the current investigation, “no‐touch” OPCAB might offer the long‐term survival benefit of CABG over PCI,2, 35 together with similar or lower than PCI 30‐day stroke rates 36, 37. The discussion about potential shortcomings of CABG as compared to PCI was fueled after the first large industry‐funded trial3 found significantly higher rates of major adverse cardiac and cerebrovascular events in the PCI group (17.8% versus 12.4% for CABG; P =0.002), in large part because of an increased rate of repeat revascularization (13.5% versus 5.9%); however, at 12 months, strokes were 4‐fold more likely to occur with CABG (2.2% versus 0.6% with PCI; P =0.003). None of the following studies comparing PCI with OPCAB38, 39, 40, 41 were powered for stroke, and none reports the extent of “no‐touch” technique in the CABG group.…”
Section: Discussionmentioning
confidence: 94%
“…Fractional flow reserve (FFR) is currently the standard for decision‐making regarding revascularization in the catheter laboratory and has become part of the clinical guidelines for the assessment of the physiological significance of epicardial coronary stenosis based on sound concepts and randomized clinical trials 8, 9, 10, 11. However, FFR evaluation is still underutilized; instead, coronary angiography is widely used as a gatekeeper for decision‐making of revascularization even in large clinical trials 2, 12. Subanalysis of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) trial has shown that angiography is inaccurate for assessing the functional significance of coronary stenosis when compared with FFR guidance, especially for intermediate stenosis 6.…”
Section: Introductionmentioning
confidence: 99%
“…The primary aim of SYNTAX was to assess the optimal revascularization strategy for patients with 3‐vessel disease or left main trunk disease, by randomizing patients to PCI with paclitaxel‐eluting DES or CABG 58. This trial demonstrated a significantly higher occurrence of major adverse cardiovascular and cerebrovascular events among patients treated with PCI as compared to CABG 58.…”
Section: Lessons Learned From Complex Percutaneous Coronary Interventmentioning
confidence: 99%